New Lipocell publication on MDPI Processes

New Lipocell publication on MDPI Processes

We are happy to share our latest publication in the Special Issue entitled “Advances in Regenerative Medicine and Tissue Engineering” by MDPI Processes magazine. In this last article, we characterized Lipocell from the cellular and histological point of view. The following paragraphs are technical hints dedicated to experts in this field. Casual readers can jump to the conclusion of the article.



The mechanism of function of Lipocell technology is a dialysis membrane that separates the elements of a solution, in this case, the lipoaspirate. The filter has a porosity equal to 50 µm that retains adipose tissue, but permeable to washing solution, blood, and excess oil. The mesenchymal stem cell (MSCs) count was performed by comparing the standard device with smaller filters (15 and 20 µm). Lipocell, on average, has 2-3 times more MSCs than untreated fat. At the same time, no differences were found between the different filters, suggesting that a filter with lower porosity is not useful to retain more cells.



Excess blood and oil can be problematic in lipofilling procedures (when adipose tissue is re-filled into the patient for filling or regenerative purposes). They are waste residues, without any recognized biological activity, which can cause inflammatory reactions. The 50 µm Lipocell filter can purify tissue from these elements more effectively and quickly than smaller filters or other methods.



From a regulatory point of view, excessive manipulation of adipose tissue turns the product into an ATMP, which stands for Advanced Therapeutic Medicinal Product. Consequently, it should be subject to strict regulations that are not compatible with routine clinical practice. Cell culture, for example, substantially modifies the cellular product. The same happens with enzymatic digestion or significant mechanical manipulation which, by altering the structure of the tissue, is more than minimal manipulation. In our article, we have characterized the elements of the extracellular matrix through biochemical analysis and performed histologies to compare the Lipocell product with untreated and centrifuged fat. Lipocell maintains a tissue architecture fully comparable to native fat, while the centrifuged one shows a substantial alteration of the structure.



Lipocell procedure involves the use of a washing solution. Results have shown that washing with Ringer’s Lactate (instead of saline) fully preserves the proliferative potential of MSCs. The mechanism of action behind this novelty requires further investigation. Still, a possible explanation may be that the adipose tissue-derived cells, after liposuction, go into ischemic shock due to lack of oxygen (as they no longer have a vascular supply). In oxygen deficiency, the cells initiate anaerobic respiration, which is a less efficient way to produce energy, but the administration of lactate ion could compensate this reaction by restoring the Krebs cycle and thus improve cell survival.



Lipocell is a medical device classified IIa for intra-operative processing of adipose tissue. The mechanism of function is based on a dialysis membrane, which, in combination with a washing step, can separate adipose tissue from waste elements such as excess wash solution, free oil, and blood. The final product is enriched with MSCs with great regenerative potential (see our recent article: “Fat is beautiful”), with the advantage of being easily injectable and with a preserved tissue architecture that meets the most stringent regulatory requirements.

Omar Sabry



Roato, I.; Mussano, F.; Reano, S.; Boriani, F.; Margara, A.; Ferracini, R.; Adriani, E.; Sabry, O.; Fiorini, M.; Fattori, P. A Novel Method to Optimize Autologous Adipose Tissue Recovery with Extracellular Matrix Preservation. Processes 20208, 88.


Click here to download the article in PDF